Literature DB >> 9743120

Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo.

M Pooga1, U Soomets, M Hällbrink, A Valkna, K Saar, K Rezaei, U Kahl, J X Hao, X J Xu, Z Wiesenfeld-Hallin, T Hökfelt, T Bartfai, U Langel.   

Abstract

Peptide nucleic acids (PNAs) form stable and tight complexes with complementary DNA and/or RNA and would be promising antisense reagents if their cellular delivery could be improved. We show that a 21-mer PNA, complementary to the human galanin receptor type 1 mRNA, coupled to the cellular transporter peptides, transportan or pAntennapedia(43-58), is efficiently taken up into Bowes cells where they block the expression of galanin receptors. In rat, the intrathecal administration of the peptide-PNA construct results in a decrease in galanin binding in the dorsal horn. The decrease in binding results in the inability of galanin to inhibit the C fibers stimulation-induced facilitation of the rat flexor reflex, demonstrating that peptide-PNA constructs act in vivo to suppress expression of functional galanin receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743120     DOI: 10.1038/nbt0998-857

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  80 in total

Review 1.  Peptide nucleic acids: versatile tools for gene therapy strategies.

Authors:  D A Dean
Journal:  Adv Drug Deliv Rev       Date:  2000-11-15       Impact factor: 15.470

2.  PNA interference mapping demonstrates functional domains in the noncoding RNA Xist.

Authors:  A Beletskii; Y K Hong; J Pehrson; M Egholm; W M Strauss
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

3.  Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression.

Authors:  B M Tyler; K Jansen; D J McCormick; C L Douglas; M Boules; J A Stewart; L Zhao; B Lacy; B Cusack; A Fauq; E Richelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

4.  Evaluation of strategies for the intracellular delivery of proteins.

Authors:  Dongjiu Ye; Dong Xu; Alex U Singer; R L Juliano
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 5.  Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors.

Authors:  Guillaume Drin; Christophe Rousselle; Jean-Michel Scherrmann; Anthony R Rees; Jamal Temsamani
Journal:  AAPS PharmSci       Date:  2002

Review 6.  The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.

Authors:  Franck Pellestor; Petra Paulasova
Journal:  Chromosoma       Date:  2004-05-19       Impact factor: 4.316

7.  A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers.

Authors:  Hans Binder; Göran Lindblom
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

8.  Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.

Authors:  Rachel Tréhin; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle; Hanne M Nielsen
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

Review 9.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

10.  Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Ulrike Krauss; Roman Muff; Martina Meinecke; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.